Breast Cancer (Vaccines)

Cooperative Research Efforts Announced

Published in Women's Health Weekly, February 17th, 1997

Medis El Ltd., New York, New York, announced that it has entered into an agreement with the Tel Aviv University Authority for Applied Research and Industrial Development Ltd. (Ramot) to develop a vaccine against breast cancer.

The Tel Aviv scientific team already has reported considerable progress in the development of the vaccine using mice which mimick breast cancer found in humans. Mice which were immunized with the vaccine, then injected with cancer-causing cells, showed a lower incidence of tumor formation, were tumor-free for longer periods of time, and developed smaller tumors. The preliminary findings also showed that the vaccine prevented or reduced the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1997-02-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry